BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20663890)

  • 1. High affinity of interaction between superantigen and T cell receptor Vbeta molecules induces a high level and prolonged expansion of superantigen-reactive CD4+ T cells.
    Omoe K; Nunomura W; Kato H; Li ZJ; Igarashi O; Araake M; Sano K; Ono HK; Abe Y; Hu DL; Nakane A; Kiyono H; Takakuwa Y; Shinagawa K; Uchiyama T; Imanishi K
    J Biol Chem; 2010 Oct; 285(40):30427-35. PubMed ID: 20663890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mutation of F47 to A in staphylococcus enterotoxin A activates the T-cell receptor Vbeta repertoire in vivo.
    Rosendahl A; Hansson J; Antonsson P; Sékaly RP; Kalland T; Dohlsten M
    Infect Immun; 1997 Dec; 65(12):5118-24. PubMed ID: 9393804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous exposure of mice to superantigenic toxins induces a high-level protracted expansion and an immunological memory in the toxin-reactive CD4+ T cells.
    Chen L; Koyanagi M; Fukada K; Imanishi K; Yagi J; Kato H; Miyoshi-Akiyama T; Zhang R; Miwa K; Uchiyama T
    J Immunol; 2002 Apr; 168(8):3817-24. PubMed ID: 11937534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the MHC class II binding domains of staphylococcal enterotoxin A differentially affect T cell receptor Vbeta specificity.
    Newton DW; Dohlsten M; Olsson C; Segrén S; Lundin KE; Lando PA; Kalland T; Kotb M
    J Immunol; 1996 Nov; 157(9):3988-94. PubMed ID: 8892632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC class II-independent, Vbeta-specific activation of T cells by superantigen mutants fused to anti-tumor Fab fragments: implications for use in treatment of human colon carcinoma.
    Newton DW; Dohlsten M; Lando PA; Kalland T; Olsson C; Kotb M
    Int J Mol Med; 1998 Jan; 1(1):157-62. PubMed ID: 9852214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between superantigen and T-cell receptor Vbeta element determines levels of superantigen-dependent cell-mediated cytotoxicity of CD8(+) T cells in induction and effector phases.
    Li ZJ; Omoe K; Shinagawa K; Yagi J; Imanishi K
    Microbiol Immunol; 2009 Aug; 53(8):451-9. PubMed ID: 19659929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transferable anergy: superantigen treatment induces CD4+ T cell tolerance that is reversible and requires CD4-CD8- cells and interferon gamma.
    Cauley LS; Cauley KA; Shub F; Huston G; Swain SL
    J Exp Med; 1997 Jul; 186(1):71-81. PubMed ID: 9206999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further clonal expansion of T cells upon rechallenge of superantigen staphylococcal enterotoxin A.
    Aoki Y; Yoshikai Y
    Microbiol Immunol; 1997; 41(4):337-43. PubMed ID: 9159408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantation of IL-2-containing osmotic pump prolongs the survival of superantigen-reactive T cells expanded in mice injected with bacterial superantigen.
    Kuroda K; Yagi J; Imanishi K; Yan XJ; Li XY; Fujimaki W; Kato H; Miyoshi-Akiyama T; Kumazawa Y; Abe H; Uchiyama T
    J Immunol; 1996 Aug; 157(4):1422-31. PubMed ID: 8759722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.
    Lando PA; Olsson C; Kalland T; Newton D; Kotb M; Dohlsten M
    J Immunol; 1996 Oct; 157(7):2857-63. PubMed ID: 8816390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term exposure to superantigen induces p27Kip1 and Bcl-2 expression in effector memory CD4+ T cells.
    Koyanagi M; Fukada K; Uchiyama T; Yagi J; Arimura Y
    Cell Immunol; 2007 Aug; 248(2):77-85. PubMed ID: 18001700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell- and perforin-dependent depletion of B cells in vivo by staphylococcal enterotoxin A.
    Sundstedt A; Grundström S; Dohlsten M
    Immunology; 1998 Sep; 95(1):76-82. PubMed ID: 9767460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal expansion but lack of subsequent clonal deletion of bacterial superantigen-reactive T cells in murine retroviral infection.
    Aoki Y; Hiromatsu K; Usami J; Makino M; Igarashi H; Ogasawara J; Nagata S; Yoshikai Y
    J Immunol; 1994 Oct; 153(8):3611-21. PubMed ID: 7523498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of phage-displayed superantigen by binding to cell-surface MHC class II.
    Wung JL; Gascoigne NR
    J Immunol Methods; 1997 May; 204(1):33-41. PubMed ID: 9202707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced and prolonged efficacy of superantigen-induced cytotoxic T lymphocyte activity by interleukin-2 in vivo.
    Belfrage H; Dohlsten M; Hedlund G; Kalland T
    Cancer Immunol Immunother; 1995 Aug; 41(2):87-94. PubMed ID: 7656274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superantigen-related T
    Rha MS; Kim SW; Chang DY; Lee JK; Kim J; Park SH; Khalmuratova R; Lim HS; Eun KM; Hong SN; Kim DW; Shin EC
    J Allergy Clin Immunol; 2020 May; 145(5):1378-1388.e10. PubMed ID: 31987845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcal toxin-induced T cell proliferation in atopic eczema correlates with increased use of superantigen-reactive Vbeta-chains in cutaneous lymphocyte-associated antigen (CLA)-positive lymphocytes.
    Davison S; Allen M; Vaughan R; Barker J
    Clin Exp Immunol; 2000 Aug; 121(2):181-6. PubMed ID: 10931129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant Disruption of
    Chowdhary VR; Krogman A; Tilahun AY; Alexander MP; David CS; Rajagopalan G
    J Immunol; 2017 Jun; 198(11):4413-4424. PubMed ID: 28468970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pairing of Vbeta6 with certain Valpha2 family members prevents T cell deletion by Mtv-7 superantigen.
    Aude-Garcia C; Attinger A; Housset D; MacDonald HR; Acha-Orbea H; Marche PN; Jouvin-Marche E
    Mol Immunol; 2000 Nov; 37(16):1005-12. PubMed ID: 11395139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cells expressing an inflammatory phenotype are lysed by superantigen-targeted cytotoxic T cells.
    Riesbeck K; Billström A; Tordsson J; Brodin T; Kristensson K; Dohlsten M
    Clin Diagn Lab Immunol; 1998 Sep; 5(5):675-82. PubMed ID: 9729535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.